- Home
- NCTY vs ZTEK Comparison
NCTY vs ZTEK Comparison
Compare NCTY & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NCTY | ZTEK |
|---|---|---|
| Founded | 1999 | 2008 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Business Services | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.7M | 78.2M |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | NCTY | ZTEK |
|---|---|---|
| Price | $6.96 | $0.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 35.2K | ★ 94.4K |
| Earning Date | 03-27-2015 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,403,864.00 | $657,134.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2225.73 |
| 52 Week Low | $5.95 | $0.62 |
| 52 Week High | $17.83 | $1.84 |
Technical Indicators
Market Signals| Indicator | NCTY | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 55.39 |
| Support Level | $6.40 | $0.85 |
| Resistance Level | $7.16 | $1.09 |
| Average True Range (ATR) | 0.48 | 0.08 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 55.22 | 47.22 |
Price Performance
Historical ComparisonAbout NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.